rs754476100
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5
The NM_153033.5(KCTD7):c.250C>T(p.Arg84Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00000547 in 1,461,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_153033.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCTD7 | NM_153033.5 | c.250C>T | p.Arg84Trp | missense_variant | 2/4 | ENST00000639828.2 | NP_694578.1 | |
KCTD7 | NM_001167961.2 | c.250C>T | p.Arg84Trp | missense_variant | 2/5 | NP_001161433.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCTD7 | ENST00000639828.2 | c.250C>T | p.Arg84Trp | missense_variant | 2/4 | 2 | NM_153033.5 | ENSP00000492240 | A1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251448Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135894
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461804Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727216
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Progressive myoclonic epilepsy type 3 Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 13, 2021 | This sequence change replaces arginine with tryptophan at codon 84 of the KCTD7 protein (p.Arg84Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs754476100, ExAC 0.001%). This missense change has been observed in individual(s) with opsoclonus-myoclonus ataxia like syndrome (PMID: 22638565). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Human Genome Lab, NIMHANS, National Institute of Mental Health and Neuro Sciences | - | The missense variant NM_153033.5:c.250C>T; NP_694578.1:p.Arg84Trp causes a change at the same amino acid residue as a previously established pathogenic variant. The p.Arg84Trp variant is a previously reported ClinVar variant of uncertain significance Accession: VCV000469102.7. The p.Arg84Trp variant is novel (not in any individuals) in 1000 Genomes, as well as in our inhouse database . The p.Arg84Trp variant is observed in 1/33,582 (0.003%) alleles from individuals of gnomAD Latino background in gnomAD. There is a moderate physicochemical difference between arginine and tryptophan. The gene KCTD7 has a low rate of benign missense variation as indicated by a high missense variants Z-Score of 1.26. The gene KCTD7 contains 15 pathogenic missense variants, indicating that missense variants are a common mechanism of disease in this gene. The p.Arg84Trp missense variant is predicted to be damaging by both SIFT and PolyPhen2. The arginine residue at codon 84 of KCTD7 is conserved in all mammalian species. The nucleotide c.250 in KCTD7 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. The variant was observed in a compound heterozygous state with another pathogenic variant (VCV001069708.6) in this individual. In addition, the patients phenotype matches with that of the disorder caused by pathogenic variants in KCTD7 gene. For these reasons, this variant has been classified as Likely Pathogenic (PM2 PP2 PP3 PM5 PM3 PP4_Moderate). - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 26, 2022 | Variant summary: KCTD7 c.250C>T (p.Arg84Trp) results in a non-conservative amino acid change located in the Potassium channel tetramerisation-type BTB domain (IPR003131) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251448 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.250C>T has been reported in the literature in at least one compound heterozygous individual affected with Acute onset Myoclonus and Ataxia (Blumkin_2012). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One ClinVar submitter has assessed the variant since 2014 without evidence for independent evaluation: the variant was classified as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at